Integra LifeSciences Recalls Products From Boston Facility, Takes Financial Hit
Executive Summary
After consulting with the US FDA, Integra Life Sciences initiated a recall of products produced in its Boston Facility. The company expects losses of $22m.
You may also be interested in...
Class I Recall For Integra’s CereLink Intracranial Pressure Monitors
The US FDA has labelled a June recall of intracranial pressure monitors from Integra with its most serious designation, class I.
FDA’s New Dataset Aims To Assist Labs In Assessing Medical Device Biocompatibility
The US FDA’s device center has unveiled a new public dataset designed to assist chemistry laboratories in ensuring the robustness of chemical characterization methods used to assess the biocompatibility of medical devices.
Israeli Company Lands De Novo Clearance For Digital Bone Marrow Application
The US FDA has cleared a novel software application to enhance the analysis of bone marrow smears. Using the AI-powered tool, hematopathologists may be able to better diagnose various blood and marrow diseases.